SOD2 and neoplasm: While antioxidant therapy is clearly an undesirable approach in metastatic disease, pro-oxidant intervention with the combination of targeting the mechanisms that regulate antioxidants may be a beneficial strategy for tumor types that display enhanced SOD2 activity.